Free Trial

Lineage (LINE) Financials

Lineage logo
$41.46 +1.43 (+3.57%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$41.47 +0.01 (+0.02%)
As of 10/3/2025 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Lineage

Annual Income Statements for Lineage

This table shows Lineage's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
-63 -77 -664
Consolidated Net Income / (Loss)
-76 -96 -751
Net Income / (Loss) Continuing Operations
-76 -96 -751
Total Pre-Tax Income
-70 -110 -840
Total Revenue
-22 4.00 -42
Net Interest Income / (Expense)
0.00 0.00 0.00
Total Interest Income
0.00 0.00 0.00
Total Interest Expense
0.00 0.00 0.00
Total Non-Interest Income
-22 4.00 -42
Net Realized & Unrealized Capital Gains on Investments
-22 4.00 -42
Total Non-Interest Expense
-297 -398 361
Other Operating Expenses
3,872 4,092 4,117
Depreciation Expense
480 552 659
Amortization Expense
198 208 217
Impairment Charge
15 32 57
Restructuring Charge
66 60 651
Other Special Charges
-4,928 -5,342 -5,340
Nonoperating Income / (Expense), net
-345 -512 -437
Income Tax Expense
6.00 -14 -89
Net Income / (Loss) Attributable to Noncontrolling Interest
-13 -19 -87
Basic Earnings per Share
($0.51) ($0.73) ($3.70)
Weighted Average Basic Shares Outstanding
152M 162M 191M
Diluted Earnings per Share
($0.51) ($0.73) ($3.70)
Weighted Average Diluted Shares Outstanding
152M 162M 191M
Weighted Average Basic & Diluted Shares Outstanding
- - 228.20M
Cash Dividends to Common per Share
- $0.55 $0.91

Quarterly Income Statements for Lineage

This table shows Lineage's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q2 2024 Q3 2024 Q1 2025
Period end date 6/30/2023 9/30/2023 6/30/2024 9/30/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-5.00 -39 -68 -485 0.00
Consolidated Net Income / (Loss)
-8.00 -50 -80 -543 0.00
Net Income / (Loss) Continuing Operations
-8.00 -50 -80 -543 0.00
Total Pre-Tax Income
-8.00 -55 -73 -588 8.00
Total Revenue
-3.00 -5.00 2.00 8.00 16
Net Interest Income / (Expense)
0.00 0.00 0.00 0.00 0.00
Total Interest Income
0.00 0.00 0.00 0.00 0.00
Total Interest Expense
0.00 0.00 0.00 0.00 0.00
Total Non-Interest Income
-3.00 -5.00 2.00 8.00 16
Net Realized & Unrealized Capital Gains on Investments
-3.00 -5.00 2.00 8.00 16
Total Non-Interest Expense
-111 -97 -74 515 -56
Other Operating Expenses
1,029 1,021 1,018 1,040 1,030
Depreciation Expense
136 137 164 156 158
Amortization Expense
52 51 55 54 54
Impairment Charge
3.00 4.00 15 8.00 -21
Restructuring Charge
15 19 12 592 15
Other Special Charges
-1,346 -1,329 -1,338 -1,335 -1,292
Nonoperating Income / (Expense), net
-116 -147 -149 -81 -64
Income Tax Expense
0.00 -5.00 7.00 -45 8.00
Net Income / (Loss) Attributable to Noncontrolling Interest
-3.00 -11 -12 -58 0.00
Basic Earnings per Share
($0.08) ($0.26) ($0.46) ($2.44) $0.01
Weighted Average Basic Shares Outstanding
162M 162M 162M 210M 228M
Diluted Earnings per Share
($0.08) ($0.26) ($0.46) ($2.44) $0.01
Weighted Average Diluted Shares Outstanding
162M 162M 162M 210M 228M
Weighted Average Basic & Diluted Shares Outstanding
- - 227.69M 228.41M 228.59M

Annual Cash Flow Statements for Lineage

This table details how cash moves in and out of Lineage's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
-38 -131 104
Net Cash From Operating Activities
501 796 703
Net Cash From Continuing Operating Activities
501 796 703
Net Income / (Loss) Continuing Operations
-76 -96 -751
Consolidated Net Income / (Loss)
-76 -96 -751
Provision For Loan Losses
5.00 6.00 5.00
Depreciation Expense
678 760 876
Amortization Expense
17 21 19
Non-Cash Adjustments to Reconcile Net Income
2.00 3.00 609
Changes in Operating Assets and Liabilities, net
-125 102 -55
Net Cash From Investing Activities
-2,369 -1,066 -919
Net Cash From Continuing Investing Activities
-2,369 -1,066 -919
Purchase of Property, Leasehold Improvements and Equipment
-813 -766 -691
Purchase of Investment Securities
-1,652 -319 -355
Sale and/or Maturity of Investments
3.00 19 127
Net Cash From Financing Activities
1,840 136 320
Net Cash From Continuing Financing Activities
1,829 136 320
Issuance of Debt
3,411 1,431 6,593
Issuance of Common Equity
0.00 -6.00 4,879
Repayment of Debt
-2,255 -1,312 -10,624
Repurchase of Common Equity
0.00 -12 -42
Payment of Dividends
-191 -46 -234
Other Financing Activities, Net
864 81 -252
Effect of Exchange Rate Changes
-10 3.00 0.00
Cash Interest Paid
354 594 523
Cash Income Taxes Paid
74 31 36

Quarterly Cash Flow Statements for Lineage

This table details how cash moves in and out of Lineage's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2023 12/31/2023 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents
-29 -41 336 -237 22
Net Cash From Operating Activities
229 231 186 257 139
Net Cash From Continuing Operating Activities
229 231 186 257 139
Net Income / (Loss) Continuing Operations
-50 -57 -543 -80 0.00
Consolidated Net Income / (Loss)
-50 -57 -543 -80 0.00
Provision For Loan Losses
2.00 2.00 1.00 2.00 1.00
Depreciation Expense
188 203 210 236 212
Amortization Expense
5.00 5.00 4.00 3.00 2.00
Non-Cash Adjustments to Reconcile Net Income
21 -3.00 493 97 24
Changes in Operating Assets and Liabilities, net
63 81 21 -1.00 -100
Net Cash From Investing Activities
-191 -421 -138 -383 -138
Net Cash From Continuing Investing Activities
-191 -421 -138 -383 -138
Purchase of Property, Leasehold Improvements and Equipment
-177 -161 -153 -205 -151
Acquisitions
- -1.00 3.00 - 0.00
Purchase of Investment Securities
-38 -265 -39 -246 -6.00
Sale and/or Maturity of Investments
24 6.00 51 71 19
Net Cash From Financing Activities
-64 146 284 -108 21
Net Cash From Continuing Financing Activities
-64 146 284 -108 21
Issuance of Debt
346 606 1,446 308 582
Repayment of Debt
-395 -427 -5,883 -273 -423
Repurchase of Common Equity
- -9.00 - -17 0.00
Payment of Dividends
- -46 - -145 -134
Other Financing Activities, Net
127 28 -158 19 -4.00
Effect of Exchange Rate Changes
-3.00 3.00 4.00 -3.00 0.00
Cash Interest Paid
163 148 135 69 86
Cash Income Taxes Paid
-10 -1.00 2.00 6.00 1.00

Annual Balance Sheets for Lineage

This table presents Lineage's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024
Period end date 12/31/2023 12/31/2024
Total Assets
18,871 18,661
Cash and Due from Banks
68 173
Restricted Cash
3.00 2.00
Trading Account Securities
113 124
Loans and Leases, Net of Allowance
0.00 0.00
Premises and Equipment, Net
10,571 10,627
Goodwill
3,394 3,338
Intangible Assets
1,280 1,127
Other Assets
3,442 3,270
Total Liabilities & Shareholders' Equity
18,871 18,661
Total Liabilities
12,849 8,967
Short-Term Debt
134 190
Other Short-Term Payables
1,137 1,303
Long-Term Debt
10,263 6,155
Other Long-Term Liabilities
1,330 1,319
Commitments & Contingencies
0.00 0.00
Redeemable Noncontrolling Interest
349 43
Total Equity & Noncontrolling Interests
5,673 9,651
Total Preferred & Common Equity
5,051 8,638
Preferred Stock
1.00 0.00
Total Common Equity
5,050 8,638
Common Stock
5,963 10,766
Retained Earnings
-879 -1,855
Accumulated Other Comprehensive Income / (Loss)
-34 -273
Noncontrolling Interest
622 1,013

Quarterly Balance Sheets for Lineage

This table presents Lineage's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q1 2025
Period end date 6/30/2024 9/30/2024 3/31/2025
Total Assets
18,756 19,256 18,768
Cash and Due from Banks
73 409 197
Trading Account Securities
123 120 128
Loans and Leases, Net of Allowance
0.00 0.00 0.00
Premises and Equipment, Net
10,491 11,324 10,644
Goodwill
3,361 3,444 3,379
Intangible Assets
1,218 1,221 1,116
Other Assets
3,487 2,735 3,304
Total Liabilities & Shareholders' Equity
18,756 19,256 18,768
Total Liabilities
13,002 9,134 9,122
Short-Term Debt
50 136 189
Other Short-Term Payables
1,172 1,359 1,132
Long-Term Debt
10,593 4,955 5,130
Other Long-Term Liabilities
1,187 2,684 2,602
Commitments & Contingencies
0.00 0.00 0.00
Redeemable Noncontrolling Interest
262 39 41
Total Equity & Noncontrolling Interests
5,492 10,083 9,605
Total Preferred & Common Equity
4,878 9,026 8,586
Total Common Equity
4,877 9,026 8,586
Common Stock
5,983 10,746 10,793
Retained Earnings
-987 -1,662 -1,976
Accumulated Other Comprehensive Income / (Loss)
-119 -58 -231
Noncontrolling Interest
614 1,057 1,019

Annual Metrics And Ratios for Lineage

This table displays calculated financial ratios and metrics derived from Lineage's official financial filings.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - -
Revenue Growth
0.00% 118.18% -1,150.00%
EBITDA Growth
0.00% 21.96% -58.41%
EBIT Growth
0.00% 46.18% -200.25%
NOPAT Growth
0.00% 46.18% -200.25%
Net Income Growth
0.00% -26.32% -682.29%
EPS Growth
0.00% -43.14% -406.85%
Operating Cash Flow Growth
0.00% 58.88% -11.68%
Free Cash Flow Firm Growth
0.00% 0.00% 100.61%
Invested Capital Growth
0.00% 0.00% -2.31%
Revenue Q/Q Growth
0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00%
Profitability Metrics
- - -
EBITDA Margin
0.00% 29,575.00% 0.00%
EBIT Margin
0.00% 10,050.00% 0.00%
Profit (Net Income) Margin
0.00% -2,400.00% 0.00%
Tax Burden Percent
108.57% 87.27% 89.40%
Interest Burden Percent
-25.45% -27.36% 208.44%
Effective Tax Rate
0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 3.43% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -3.83% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% -6.62% 0.00%
Return on Equity (ROE)
0.00% -3.19% -9.56%
Cash Return on Invested Capital (CROIC)
0.00% -196.57% 0.60%
Operating Return on Assets (OROA)
0.00% 2.13% 0.00%
Return on Assets (ROA)
0.00% -0.51% 0.00%
Return on Common Equity (ROCE)
0.00% -2.67% -8.32%
Return on Equity Simple (ROE_SIMPLE)
0.00% -1.90% -8.69%
Net Operating Profit after Tax (NOPAT)
193 281 -282
NOPAT Margin
0.00% 7,035.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
0.00% 7.26% 5.60%
SG&A Expenses to Revenue
0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% -9,950.00% 0.00%
Earnings before Interest and Taxes (EBIT)
275 402 -403
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
970 1,183 492
Valuation Ratios
- - -
Price to Book Value (P/BV)
0.00 0.88 1.55
Price to Tangible Book Value (P/TBV)
0.00 11.80 3.21
Price to Revenue (P/Rev)
0.00 1,109.20 0.00
Price to Earnings (P/E)
0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 1.55%
Earnings Yield
0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.96 1.28
Enterprise Value to Revenue (EV/Rev)
0.00 3,933.70 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 13.30 41.88
Enterprise Value to EBIT (EV/EBIT)
0.00 39.14 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 55.92 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 19.77 29.31
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 210.46
Leverage & Solvency
- - -
Debt to Equity
0.00 1.73 0.65
Long-Term Debt to Equity
0.00 1.70 0.63
Financial Leverage
0.00 1.73 1.07
Leverage Ratio
0.00 3.13 2.39
Compound Leverage Factor
0.00 -0.86 4.98
Debt to Total Capital
0.00% 63.32% 39.56%
Short-Term Debt to Total Capital
0.00% 0.82% 1.18%
Long-Term Debt to Total Capital
0.00% 62.51% 38.38%
Preferred Equity to Total Capital
0.00% 0.01% 0.00%
Noncontrolling Interests to Total Capital
0.00% 5.91% 6.58%
Common Equity to Total Capital
0.00% 30.76% 53.86%
Debt to EBITDA
0.00 8.79 12.90
Net Debt to EBITDA
0.00 8.73 12.54
Long-Term Debt to EBITDA
0.00 8.68 12.51
Debt to NOPAT
0.00 36.95 -22.49
Net Debt to NOPAT
0.00 36.70 -21.87
Long-Term Debt to NOPAT
0.00 36.47 -21.82
Noncontrolling Interest Sharing Ratio
0.00% 16.14% 12.90%
Liquidity Ratios
- - -
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
0.00 -16,138 98
Operating Cash Flow to CapEx
61.62% 103.92% 101.74%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00
Efficiency Ratios
- - -
Asset Turnover
0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00
Capital & Investment Metrics
- - -
Invested Capital
0.00 16,419 16,039
Invested Capital Turnover
0.00 0.00 0.00
Increase / (Decrease) in Invested Capital
0.00 16,419 -380
Enterprise Value (EV)
0.00 15,735 20,604
Market Capitalization
4,437 4,437 13,378
Book Value per Share
$0.00 $31.17 $37.82
Tangible Book Value per Share
$0.00 $2.32 $18.27
Total Capital
0.00 16,419 16,039
Total Debt
0.00 10,397 6,345
Total Long-Term Debt
0.00 10,263 6,155
Net Debt
0.00 10,326 6,170
Capital Expenditures (CapEx)
813 766 691
Net Nonoperating Expense (NNE)
269 377 469
Net Nonoperating Obligations (NNO)
0.00 10,397 6,345
Total Depreciation and Amortization (D&A)
695 781 895
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($3.70)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 191M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($3.70)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 191M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 228.20M
Normalized Net Operating Profit after Tax (NOPAT)
-3,200 -3,394 -3,525
Normalized NOPAT Margin
0.00% -84,840.00% 0.00%
Pre Tax Income Margin
0.00% -2,750.00% 0.00%
Debt Service Ratios
- - -
EBIT to Interest Expense
0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00
Payout Ratios
- - -
Dividend Payout Ratio
-251.32% -47.92% -31.16%
Augmented Payout Ratio
-251.32% -60.42% -36.75%

Quarterly Metrics And Ratios for Lineage

This table displays calculated financial ratios and metrics derived from Lineage's official financial filings.

Metric Q2 2023 Q3 2023 Q2 2024 Q3 2024 Q1 2025
Period end date 6/30/2023 9/30/2023 6/30/2024 9/30/2024 3/31/2025
Growth Metrics
- - - - -
Revenue Growth
0.00% 0.00% 166.67% 260.00% 188.89%
EBITDA Growth
0.00% 0.00% -0.34% -202.81% -4.67%
EBIT Growth
0.00% 0.00% -29.63% -651.09% -13.25%
NOPAT Growth
0.00% 0.00% -29.63% -651.09% -100.00%
Net Income Growth
0.00% 0.00% -900.00% -986.00% 100.00%
EPS Growth
0.00% 0.00% -475.00% -838.46% 103.57%
Operating Cash Flow Growth
0.00% 0.00% 0.00% -18.78% 32.38%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Growth
0.00% 0.00% 0.00% 0.00% 0.00%
Revenue Q/Q Growth
0.00% -66.67% 0.00% 300.00% 0.00%
EBITDA Q/Q Growth
0.00% -3.72% 0.00% -199.32% 0.00%
EBIT Q/Q Growth
0.00% -14.81% 0.00% -767.11% 0.00%
NOPAT Q/Q Growth
0.00% -14.81% 0.00% -767.11% 0.00%
Net Income Q/Q Growth
0.00% -525.00% 0.00% -578.75% 0.00%
EPS Q/Q Growth
0.00% -225.00% 0.00% -430.43% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% -45.91%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 4.75% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -7.22% 0.00%
Profitability Metrics
- - - - -
EBITDA Margin
0.00% 0.00% 14,750.00% -3,662.50% 1,787.50%
EBIT Margin
0.00% 0.00% 3,800.00% -6,337.50% 450.00%
Profit (Net Income) Margin
0.00% 0.00% -4,000.00% -6,787.50% 0.00%
Tax Burden Percent
100.00% 90.91% 109.59% 92.35% 0.00%
Interest Burden Percent
-7.41% -59.78% -96.05% 115.98% 11.11%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 100.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% 0.00% 0.00% 0.00% -7.29%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
0.00% 0.00% 0.00% 0.00% -6.49%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% -8.19%
Net Operating Profit after Tax (NOPAT)
76 64 53 -355 0.00
NOPAT Margin
0.00% 0.00% 2,660.00% -4,436.25% 0.00%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 2.50% 7.39% 0.00%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 0.00% -3,700.00% 6,437.50% -350.00%
Earnings before Interest and Taxes (EBIT)
108 92 76 -507 72
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
296 285 295 -293 286
Valuation Ratios
- - - - -
Price to Book Value (P/BV)
0.00 0.00 0.91 1.98 1.56
Price to Tangible Book Value (P/TBV)
0.00 0.00 14.89 4.09 3.27
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.48% 2.45%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.97 1.55 1.31
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 40.92
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 26.54
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - -
Debt to Equity
0.00 0.00 1.85 0.50 0.55
Long-Term Debt to Equity
0.00 0.00 1.84 0.49 0.53
Financial Leverage
0.00 0.00 1.85 0.50 0.55
Leverage Ratio
0.00 0.00 3.26 1.90 1.95
Compound Leverage Factor
0.00 0.00 -3.13 2.21 0.22
Debt to Total Capital
0.00% 0.00% 64.91% 33.46% 35.54%
Short-Term Debt to Total Capital
0.00% 0.00% 0.30% 0.89% 1.26%
Long-Term Debt to Total Capital
0.00% 0.00% 64.60% 32.57% 34.28%
Preferred Equity to Total Capital
0.00% 0.00% 0.01% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 5.34% 7.20% 7.08%
Common Equity to Total Capital
0.00% 0.00% 29.74% 59.33% 57.37%
Debt to EBITDA
0.00 0.00 0.00 0.00 11.13
Net Debt to EBITDA
0.00 0.00 0.00 0.00 10.72
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 10.73
Debt to NOPAT
0.00 0.00 0.00 0.00 -18.35
Net Debt to NOPAT
0.00 0.00 0.00 0.00 -17.67
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 -17.70
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 10.99%
Liquidity Ratios
- - - - -
Cash Flow Metrics
- - - - -
Free Cash Flow to Firm (FCFF)
0.00 0.00 -16,344 -15,568 -14,965
Operating Cash Flow to CapEx
0.00% 129.38% 0.00% 121.57% 92.05%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - -
Asset Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - -
Invested Capital
0.00 0.00 16,397 15,213 14,965
Invested Capital Turnover
0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital
0.00 0.00 16,397 15,213 14,965
Enterprise Value (EV)
0.00 0.00 15,881 23,621 19,561
Market Capitalization
4,437 4,437 4,437 17,846 13,379
Book Value per Share
$0.00 $0.00 $30.10 $39.64 $37.63
Tangible Book Value per Share
$0.00 $0.00 $1.84 $19.15 $17.93
Total Capital
0.00 0.00 16,397 15,213 14,965
Total Debt
0.00 0.00 10,643 5,091 5,319
Total Long-Term Debt
0.00 0.00 10,593 4,955 5,130
Net Debt
0.00 0.00 10,567 4,679 5,122
Capital Expenditures (CapEx)
0.00 177 0.00 153 151
Net Nonoperating Expense (NNE)
84 114 133 188 0.00
Net Nonoperating Obligations (NNO)
0.00 0.00 10,643 5,091 5,319
Total Depreciation and Amortization (D&A)
188 193 219 214 214
Earnings Adjustments
- - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($0.46) ($2.44) $0.01
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 162M 210M 228M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($0.46) ($2.44) $0.01
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 162M 210M 228M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 227.69M 228.41M 228.59M
Normalized Net Operating Profit after Tax (NOPAT)
-854 -850 -865 -869 -858
Normalized NOPAT Margin
0.00% 0.00% -43,225.00% -10,867.50% -5,363.75%
Pre Tax Income Margin
0.00% 0.00% -3,650.00% -7,350.00% 50.00%
Debt Service Ratios
- - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% -36.42%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% -38.83%

Financials Breakdown Chart

Key Financial Trends

Lineage, Inc. Financial Overview and Trends (Last Four Quarters through Q1 2025)

Lineage's recent financial results indicate a company that is generating strong non-interest income but facing significant operating expenses and fluctuating net income results on a quarterly basis. Below are the key points from the analysis of their Income Statement, Cash Flow Statement, and Balance Sheet across the last year and into Q1 2025.

  • Q1 2025 showed a notable increase in net realized and unrealized capital gains on investments ($16 million), doubling from Q3 2024 ($8 million), which supports total revenue despite no traditional interest income.
  • Net cash provided by operating activities was $139 million in Q1 2025, a sign of strong operational cash generation capability, despite a net loss figure.
  • The company maintained a strong asset base with $18.8 billion in total assets as of Q1 2025, reflecting substantial investment in property and equipment ($10.6 billion), goodwill ($3.4 billion), and intangible assets ($1.1 billion).
  • Lineage issued $582 million in new debt in Q1 2025 while repaying $423 million, maintaining a balanced financing strategy with net proceeds contributing to financing activities.
  • The company repaid $134 million in dividends in Q1 2025, continuing to provide shareholder returns.
  • There is no interest income or expense reported for recent quarters, indicating the company might be operating outside traditional interest-earning activities or finance operations presently.
  • Non-cash depreciation and amortization expenses remain high ($158 million and $54 million respectively in Q1 2025), consistent with significant property and equipment investment.
  • Despite revenue gains, Q1 2025 net income was effectively flat at $0 after tax expenses matched pre-tax income, indicative of low profitability margins.
  • Other operating expenses remain extremely high at over $1 billion per quarter, creating pressure on net income and cash flow.
  • The company recorded substantial special charges and restructuring costs in Q1 2025 (net other special charges at negative $1.29 billion and restructuring charge $15 million), which negatively impacted net income and operating results.

Summary: Lineage's financial results reveal a firm with a solid asset base and strong cash generation from operations, offset by very high operating expenses and restructuring charges that suppressed profitability. The company’s increasing capital gains on investments signal potential upside in revenue streams outside traditional interest income. However, consistently high depreciation and amortization, special charges, and restructuring costs remain headwinds.

Retail investors should watch for signs of cost control improvements and sustained capital gains to enhance profitability. Also, maintaining manageable debt levels and continuing to generate robust cash flows are positive indicators of financial stability.

10/05/25 01:24 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Lineage's Financials

When does Lineage's fiscal year end?

According to the most recent income statement we have on file, Lineage's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Lineage's net income changed over the last 2 years?

Lineage's net income appears to be on an upward trend, with a most recent value of -$751 million in 2024, rising from -$76 million in 2022. The previous period was -$96 million in 2023. See Lineage's forecast for analyst expectations on what’s next for the company.

How has Lineage's revenue changed over the last 2 years?

Over the last 2 years, Lineage's total revenue changed from -$22 million in 2022 to -$42 million in 2024, a change of 90.9%.

How much debt does Lineage have?

Lineage's total liabilities were at $8.97 billion at the end of 2024, a 30.2% decrease from 2023, and a 30.2% decrease since 2023.

How much cash does Lineage have?

In the past 1 years, Lineage's cash and equivalents has ranged from $68 million in 2023 to $173 million in 2024, and is currently $173 million as of their latest financial filing in 2024.

How has Lineage's book value per share changed over the last 2 years?

Over the last 2 years, Lineage's book value per share changed from 0.00 in 2022 to 37.82 in 2024, a change of 3,781.8%.



This page (NASDAQ:LINE) was last updated on 10/5/2025 by MarketBeat.com Staff
From Our Partners